TOUCAN CAPITAL
Toucan Capital Fund II, L.P. is a $140 million venture capital fund focused on seed and early-stage life science and advanced technology investments. Toucan Capital Corp. launched its first fund in 1997 and began investing its current fund in August of 2001. Toucan invests nationwide and is one of the largest and most active venture capital funds in seed and early-stage life science. Toucan has also been an early investor in nanotechnology. Toucan is especially active in the mid-Atlantic region, one of the richest markets in the country for life science and certain advanced technologies, and a market that has generally been underserved by venture capital.
TOUCAN CAPITAL
Social Links:
Industry:
Biotechnology Life Science Medical Device Pharmaceutical
Founded:
2001-01-01
Status:
Closed
Contact:
(240) 497-4060
Email Addresses:
[email protected]
Technology used in webpage:
SPF Google Apps For Business DMARC Google DNS Google Domains Google Cloud DNS AppRiver Atlantech Online
Current Employees Featured
Founder
Investments List
| Date | Company | Article | Money raised |
|---|---|---|---|
| 2019-06-10 | INmuneBIO | Toucan Capital investment in Post-IPO Equity - INmuneBIO | 7 M USD |
| 2008-05-02 | Reactive NanoTechnologies | Toucan Capital investment in Series D - Reactive NanoTechnologies | 4.8 M USD |
| 2008-02-15 | Q Therapeutics | Toucan Capital investment in Venture Round - Q Therapeutics | 15 M USD |
| 2008-01-07 | Reactive NanoTechnologies | Toucan Capital investment in Series C - Reactive NanoTechnologies | 6.35 M USD |
| 2004-08-03 | Pepgen | Toucan Capital investment in Series D - Pepgen | 7.5 M USD |
| 2004-07-14 | Intrapace | Toucan Capital investment in Series C - Intrapace | 14.6 M USD |
| 2004-03-05 | Reactive NanoTechnologies | Toucan Capital investment in Series B - Reactive NanoTechnologies | 8.24 M USD |
| 2003-01-03 | Reactive NanoTechnologies | Toucan Capital investment in Series A - Reactive NanoTechnologies | 1.05 M USD |